Extensive Decay in Primary Molars
Conditions
Brief summary
A clinical trial to evaluate and compare three different products used for endodontic treatment (taking the infected nerve out of the teeth) of primary teeth. Null Hypothesis: The new biological products (WMTA and Biodentine) behave as good as the former iodoform product.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients (Children with carious deciduous molars indicated for pulpotomy) belonging to the category of ASA I according to the 'American Society of Anaesthesiologists'. * Patients without any known medical history of systemic complications contradicting pulp treatment. * Patients are indicated for treatment under general anaesthesia due to polycaries / fear / anxiety / very young age. * Written consent is obtained from the parent/guardian after explaining the full details of the treatment procedure and its possible outcomes.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical successes after pulpotomy. | at baseline visit | clinical evaluation and radiography of the tooth is performed. Clinical criteria: abscence of post-operative pain, absence of pain on percussion and palpation, absence of abscess or swelling, absence of sinus tract or fistula and absence of pathologic tooth mobility. |
| Clinical success after pulpotomy. | 3 months after pulpotomy. | clinical evaluation and radiography of the tooth is performed. Clinical criteria: abscence of post-operative pain, absence of pain on percussion and palpation, absence of abscess or swelling, absence of sinus tract or fistula and absence of pathologic tooth mobility. |
| Radiographic successes after pulpotomy. | at baseline visit | Radiographic criteria: presence of normal periodontal ligament space, absence of internal or external root resorption, absence of canal calcification, absence of periradicular radiolucency and no loss or break of lamina dura. |
Countries
Belgium